Showing results (1-10 of 215) with videos related to
Sort By:
Pageof 22
Expert Review of Vaccines|February 19, 2013
Virus-like particle-based vaccines against hepatitis C virus infectionBertrand Bellier, David KlatzmannBMC Immunology|August 21, 2004
In situ transduction of stromal cells and thymocytes upon intrathymic injection of lentiviral vectorsGilles Marodon, David KlatzmannFrontiers in Immunology|March 16, 2019
Interleukin-1 in the Response of Follicular Helper and Follicular Regulatory T CellsPaul-Gydéon Ritvo, David KlatzmannNature Reviews. Immunology|April 18, 2015
The promise of low-dose interleukin-2 therapy for autoimmune and inflammatory diseasesDavid Klatzmann, Abul K AbbasImmunity, Inflammation and Disease|December 10, 2021
Anakinra reduces lung inflammation in experimental acute lung injuryPaul Engeroff, Aude Belbézier, Antoine Monsel, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|January 25, 2007
Replication-competent vectors and empty virus-like particles: new retroviral vector designs for cancer gene therapy or vaccinesCharlotte Dalba, Bertrand Bellier, Noriyuki Kasahara, et al.Current Diabetes Reports|October 27, 2014
Interleukin 2 in the pathogenesis and therapy of type 1 diabetesMichelle Rosenzwajg, Guillaume Churlaud, Agnès Hartemann, et al.Current Gene Therapy|February 7, 2006
Beyond oncolytic virotherapy: replication-competent retrovirus vectors for selective and stable transduction of tumorsCharlotte Dalba, David Klatzmann, Christopher R Logg, et al.Plos One|July 31, 2012
State-transition diagrams for biologistsHugues Bersini, David Klatzmann, Adrien Six, et al.Nature Reviews. Rheumatology|November 3, 2021
Interleukin-2 and regulatory T cells in rheumatic diseasesAntonios G A Kolios, George C Tsokos, David KlatzmannPageof 22